Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 

News & events

RSS feeds RSS feeds

Our latest announcements

16/07/2012 — Lifetime Achievement in Cancer Research Prize Winner 2012
19/06/2012 — Research Bursaries – call for applications
03/05/2012 — New Investigator Awards
22/03/2012 — Changes to our funding committees and schemes
15/11/2011 — Research Update issue 7 published
21/07/2011 — Research Update issue 6 published
18/07/2011 — Chris Marshall wins Lifetime Achievement Award
14/07/2011 — Cancer Research UK participates in ICGC
11/07/2011 — Cancer Research UK funds 10 new investigators
30/06/2011 — Revised Terms and conditions 2011
See all announcements ›

RSS FeedLatest cancer news


How to subscribe

Advanced search

  1. Press Release: MPs sent cigarette packs to highlight their deadly design

    12 Feb 2013

    Westminster MPs are being sent examples of widely available cigarette packets to show how the tobacco industry markets its products to children today (Tuesday).

  2. Press Release: Late diagnosis and lack of treatment access may contribute to poor UK lung cancer survival

    11 Feb 2013

    The UK's one-year lung cancer survival lags behind Australia, Canada, Denmark, Norway and Sweden according to a new international study published today (Monday).

  3. News story: Genetically engineered virus extends the lives of terminally-ill liver cancer patients

    11 Feb 2013

    A genetically-engineered virus has prolonged the lives of terminally ill liver cancer patients in a small clinical trial.

  4. Press Release: Early results show two drugs may be better than one to treat most deadly skin cancer

    11 Feb 2013

    Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.

  5. News story: 'DNA editing' enzyme could fuel breast cancer

    8 Feb 2013

    Genetic errors driving the majority of breast cancers may be caused by a hyperactive enzyme called APOBEC3B, according to US researchers.